Rabbit Allergy: The Secretoglobin Allergen That Does Not Cross-React with Cats

Rabbit allergy symptoms typically develop within minutes of contact with the animal or its environment and include nasal congestion, sneezing, runny nose, and itchy or watery eyes. Direct skin contact with the rabbit — particularly when the animal licks the owner — can produce localized hives or redness from salivary allergen delivery via Ory c 1. In more sensitized individuals, chest tightness and wheezing signal lower airway involvement consistent with developing asthma. Symptoms that are consistently worse during cage cleaning, when hay bedding particles become airborne, may indicate concurrent storage mite sensitization in addition to direct rabbit allergy. Anaphylaxis from rabbit allergen is rare but documented.

No — rabbit allergy and cat allergy are diagnostically independent despite an interesting structural similarity between their major allergens. The major rabbit allergen Ory c 3 and the major cat allergen Fel d 1 are both secretoglobins — members of the same rare protein superfamily — but a definitive study by Hilger et al. (Journal of Allergy and Clinical Immunology 2014) confirmed no IgE cross-reactivity between these two proteins. This means testing positive for rabbit allergy does not predict cat allergy, and vice versa. Patients with both a cat and a rabbit who develop allergy symptoms need specific IgE testing for both allergens separately, and immunotherapy must target each species independently.

Yes — rabbit hay bedding can be an independent allergic trigger separate from the rabbit itself. Timothy hay and orchard grass hay commonly harbor storage mites, including Lepidoglyphus destructor and Tyrophagus putrescentiae, which are potent allergens in their own right. A rabbit owner may be allergic to both rabbit proteins (Ory c 3 from dander) and storage mites (from the hay), or potentially to storage mites alone. Specific IgE testing for storage mites alongside rabbit allergen clarifies the picture. Switching from hay to paper-based or wood pellet bedding eliminates the storage mite allergen source and can provide substantial symptom relief in patients with dual sensitization.

Yes — late-onset rabbit allergy after years of apparently asymptomatic ownership is a recognized clinical pattern. Allergic sensitization is a cumulative immune process: the body progressively produces IgE antibodies with repeated allergen exposure, and symptoms may not appear until sensitization exceeds a threshold that triggers symptomatic mast cell activation. A change in housing situation — moving from a large home to a smaller apartment, for example — can dramatically increase allergen concentration and unmask previously subclinical sensitization. Hormonal changes, concurrent respiratory infections, or new additional allergen exposures can also lower the allergic threshold. A specific IgE test will confirm whether sensitization has developed.

No rabbit breed has been scientifically proven to produce significantly less Ory c 3 or other allergens than other breeds. The 'hypoallergenic rabbit breed' concept lacks scientific validation, paralleling similar myths about hypoallergenic cats and dogs. However, rabbit breeds do vary meaningfully in shedding behavior: heavy-shedding breeds like Angoras distribute dander-laden hair throughout the home far more extensively than short-haired breeds like Rex or Dutch rabbits. While this does not reduce allergen production, it does reduce the environmental dispersal of allergen. For allergic households considering rabbit adoption, short-haired breeds in a well-ventilated space represent a more manageable starting point, ideally alongside formal allergy testing before adoption.

Ory c 3 is the major allergen of domestic rabbits — an 18-19 kilodalton secretoglobin protein found in rabbit hair and dander that sensitizes approximately 77% of rabbit-allergic patients. It is the only mammalian secretoglobin allergen besides Fel d 1 (cat), making it a molecularly unique allergen within the small mammal allergy landscape. Identifying Ory c 3 sensitization is clinically important because: it is the dominant sensitizer in most rabbit-allergic patients; it is allergenically independent from cat allergen Fel d 1 despite structural homology; and allergen immunotherapy must specifically target Ory c 3 rather than using cat allergen extracts as a proxy. Component-resolved diagnostics for Ory c 3 provides the most precise diagnosis.

Without intervention, rabbit allergy typically worsens with continued allergen exposure as the immune system becomes progressively more sensitized. What begins as mild nasal symptoms may progress over months to years to include more persistent congestion, recurrent sinusitis, and eventually lower airway involvement with asthma in susceptible individuals. This progressive sensitization pattern is common to all IgE-mediated pet allergies. The best protection against progression is early diagnosis and either allergen avoidance with strong environmental controls, or allergen immunotherapy to build immune tolerance. Patients who pursue immunotherapy during the mild-to-moderate symptom phase generally have better outcomes than those who delay until disease is more advanced.

Yes — allergen immunotherapy is available and effective for rabbit allergy. Both subcutaneous immunotherapy (allergy shots using rabbit allergen extract) and sublingual immunotherapy (allergen drops under the tongue) follow the established mechanism of gradually building immune tolerance to rabbit proteins over a 3-5 year treatment course. A key consideration is that the immunotherapy must specifically target rabbit allergens — particularly Ory c 3 — rather than using cat or other pet allergen extracts as surrogates, since Ory c 3 does not cross-react with Fel d 1. Confirmation of rabbit-specific IgE through blood or skin prick testing before starting immunotherapy ensures the treatment is matched to the actual allergen driving the patient's symptoms.